XML 30 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:        
Net income (loss) $ (37,868) $ (17,705)    
Adjustments to reconcile net loss to cash used in by operating activities:        
Depreciation and amortization 1,038 1,135    
Allowance for doubtful accounts 1 0    
Stock-based compensation 3,695 555    
Amortization of operating right of use assets 590 764    
Provision for excess and obsolete inventory 265 215    
Non-cash interest expense on government payable 1,902 601    
Venture loan interest and final payment fee 1,808 0    
Grant income 0 (9,135)    
Fair Value Adjustment of Warrants (2,603) 0    
Gain on investments in marketable securities 0 (1,164)    
Non-cash lease expense 0 (756)    
(Gain) loss on marketable securities 0 (1,164)    
Unrealized foreign exchange loss (gain) (1,226) 15    
Change in operating assets and liabilities:        
Trade accounts receivable (320) (334)    
Research incentives receivable 579 (10,374)    
Inventories (684) (29)    
Deferred offering costs 1,250 0    
Prepaid expenses and other current assets (7,074) (929)    
Trade accounts payable 1,049 (1,081)    
Right-of-use assets (97) 0    
Accrued expenses and other current liabilities 1,704 (313)    
Deferred revenue, current (730) (148)    
Loan program payable 0 11,068    
Current portion of long-term debt 2,893 0    
Operating lease liability (442) 0    
Net cash used in operating activities (34,270) (27,615)    
Cash flows from investing activities:        
Purchase of property and equipment (249) (1,493)    
Purchase of software (67) (214)    
Net cash used in investing activities (316) (1,707)    
Cash flows from financing activities:        
Proceeds from issuance of common stock from the PIPE investment (Note 3) 40,000 0    
Business Combination, net of redemption and transaction costs (Note 3) 4,100 0    
Transaction costs paid directly by D-Wave Systems (6,528) 0    
Proceeds from exercise of public warrants 910 0    
Proceeds from promissory note - related party 420 0    
Proceeds from government assistance 3,124 16,346    
Proceeds from issuance of common stock upon exercise of stock options 72 66    
Proceeds from debt financing 19,870 0    
Payment for directors and officers insurance (864) 0    
Debt payments (20,000) (23)    
Venture loan interest and final payment fee (1,808) 0    
Government loan payment (398) (399)    
Net cash provided by financing activities 38,898 15,990    
Effect of exchange rate changes on cash and cash equivalents (31) 42    
Net (decrease) increase in cash and cash equivalents 4,281 (13,290)    
Cash and cash equivalents at beginning of period 9,483 21,335 $ 21,335  
Cash and cash equivalents at end of period 13,764 8,045 9,483 $ 21,335
Supplemental disclosure of noncash investing and financial activities:        
Initial warrant liabilities recognized in connection with closing of Business Combination 8,101 0    
Non-cash Business Combination financing (11,400) 0    
Stock Issued 3,271 0    
Conversion of convertible preferred stock to common stock 189,871 0    
Public Warrants [Member]        
Adjustments to reconcile net loss to cash used in by operating activities:        
Fair Value Adjustment of Warrants (1,483) 0    
Private Warrants [Member]        
Adjustments to reconcile net loss to cash used in by operating activities:        
Fair Value Adjustment of Warrants (1,120) 0    
DWave System [Member]        
Cash flows from operating activities:        
Net income (loss)     (31,545) (10,019)
Adjustments to reconcile net loss to cash used in by operating activities:        
Depreciation and amortization     1,534 1,886
Stock-based compensation     1,739 2,989
Amortization of operating right of use assets     1,068 840
Provision for excess and obsolete inventory     269 246
Non-cash interest expense on government assistance     1,722 137
Non-cash interest expense on convertible debt       5,095
Gain on settlement of warrant liability     0 (7,836)
Gain on investments in marketable securities     (1,163) 0
Gain on debt extinguishment     0 (3,873)
Interest benefit on debt     (19)  
Government assistance     (7,140) (12,027)
Fair value of warrants issued for services       451
Non-cash lease expense       201
Unrealized foreign exchange loss (gain)     (100) (287)
Change in operating assets and liabilities:        
Trade accounts receivable     163 8,002
Research incentives receivable     2,236 (9,053)
Inventories     182 (652)
Prepaid expenses and other current assets     (1,012) (16)
Trade accounts payable     (379) 1,279
Accrued expenses and other current liabilities     578 (5,579)
Deferred revenue, current     (1,902) (335)
Operating lease liability     (1,031) (736)
Net cash used in operating activities     (34,800) (29,287)
Cash flows from investing activities:        
Purchase of property and equipment     (1,774) (736)
Purchase of software     (225) (53)
Net cash used in investing activities     (1,999) (789)
Cash flows from financing activities:        
Proceeds from issuance of preferred stock for cash     43,600 43,679
Share issuance costs       (542)
Proceeds from government assistance     25,147  
Proceeds from issuance of common stock upon exercise of stock options     85 5
Proceeds from debt financing     111  
Debt payments     (31)  
Government loan payment     (399)  
Proceeds from exercise of warrants       2
Net cash provided by financing activities     24,913 43,144
Effect of exchange rate changes on cash and cash equivalents     34 (13)
Net (decrease) increase in cash and cash equivalents     (11,852) 13,055
Cash and cash equivalents at beginning of period $ 9,483 $ 21,335 21,335 8,280
Cash and cash equivalents at end of period     9,483 21,335
Supplemental disclosure of noncash investing and financial activities:        
Operating lease right-of-use assets recognized in exchange for new operating lease obligations     11,870 4,932
Acquisition of property and equipment included in accounts payable     14 (79)
Cash payments included in the measurement of operating lease liabilities     1,573 $ 1,474
Unpaid deferred costs     $ 1,142